Late mortality among survivors of childhood acute lymphoblastic leukemia diagnosed during 1971–2008 in Denmark, Finland, and Sweden: A population-based cohort study

An interesting article from Sørensen et al. about long term survival from childhood ALL (acute lymphoblastic leukemia). According to this article the long term results have improved decade after decade. Still there is space for improvements. Even if it is a small part of the whole ALL treatment protocol, it is worth having the lumbar punctures right the first time.

“Among ALL survivors, it was found that late mortality continued to decrease over treatment decades. This was highly attributable to a decrease in mortality from relapse.”

Read the publication from here: Late mortality among survivors of childhood acute lymphoblastic leukemia diagnosed during 1971–2008 in Denmark, Finland, and Sweden: A population-based cohort study Pediatr Blood Cancer. 2022;

Gitte V. Sørensen1,2 Federica Belmonte3 Friederike Erdmann4,5 Hanna Mogensen6 Vanna Albieri3 Anna S. Holmqvist7 Laura Madanat-Harjuoja8 Mats Talbäck6 Mats M. Heyman9 Nea Malila8 Maria Feychting6
Kjeld Schmiegelow10 Jeanette F. Winther2,4 Henrik Hasle1

1 Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
2 Department of Clinical Medicine, Faculty of Health, Aarhus University and University Hospital, Aarhus, Denmark
3 Unit of Statistics and Data Analysis, Danish Cancer Society Research Center, Copenhagen, Denmark
4 Childhood Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark
5 Division of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg
University Mainz, Mainz, Germany
6 Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
7 Department of Clinical Sciences, Lund University, Pediatric Oncology and Hematology, Skåne University Hospital, Lund, Sweden
8 Finnish Cancer Registry, Helsinki, Finland
9 Childhood Cancer Research Unit, Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden
10 Institute of Clinical Medicine, Faculty of Medicine, University of Copenhagen, Copenhagen, Denmark

 

Injeq webinar today, Thursday Feb 22nd, 2024

Welcome to the webinar “Innovation in lumbar punctures” on February 22nd, 2024, at 7:00 pm (Madrid time Zone)   Lecturers […]
Read more »

INJEQ IQ-Tip Webinar February 22nd, 2024

Join the webinar revealing the revolutionary technique of lumbar punctures for healthcare professionals. Discover the innovative technology behind Injeq IQ-Tip®, […]
Read more »

HKTDC London office is proud of INJEQ’s achievements

The Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong […]
Read more »

EGM March 1, 2024

NOTICE OF THE EXTRAORDINARY GENERAL MEETING KUTSU YLIMÄÄRÄISEEN YHTIÖKOKOUKSEEN Notice is given to the shareholders of Injeq Oyj of the […]
Read more »

Arab Health 2024 started – Injeq meets with customers

Arab Health 2024, the intersection of cutting-edge technologies, revolutionary concepts, and healthcare experts, is reshaping the healthcare landscape. Injeq CEO […]
Read more »

Season greetings!

Injeq kiittää kaikkia asiakkaitaan ja sidosryhmiään yhteistyöstä vuonna 2023 ja toivottaa rauhallista joulun aikaa! Onnea ja iloa uuteen vuoteen 2024! […]
Read more »